Diabetes Care, Vol 20, Issue 2 194-197, Copyright © 1997 by American Diabetes Association

ARTICLES

Total radical-trapping antioxidant parameter in NIDDM patients

A Ceriello, N Bortolotti, E Falleti, C Taboga, L Tonutti, A Crescentini, E Motz, S Lizzio, A Russo and E Bartoli
Department of Medicine and Pathology, Clinical and Experimental, University of Udine, Italy.

OBJECTIVE: The existence of an oxidative stress in diabetes is still debated. This is largely due to the lack of good tools to assay the level of oxidative stress. The use of total radical-trapping antioxidant parameter (TRAP) has recently been proposed to explore the antioxidant property of a plasma sample. TRAP may be either directly measured by a fluorescence-based method (TRAPm) or calculated (TRAPc) by a mathematical formula, taking into account the serum levels of four natural antioxidants: protein-bound SH (thiol) groups, uric acid, vitamin E, and vitamin C. The difference between TRAPm and TRAPc is due to antioxidants, which are still unidentified, and to the possible synergism among the antioxidants. RESEARCH DESIGN AND METHODS: In this study, we evaluated malondialdehyde (MDA), TRAPm, TRAPc, protein-bound SH groups, uric acid, vitamin E, and vitamin C in 40 NIDDM patients and 40 matched normal control subjects. RESULTS: TRAPm and TRAPc were significantly lower in diabetic patients. A good correlation between TRAPm and TRAPc was found in both NIDDM patients (r = 0.68, P < 0.0001) and control subjects (r = 0.74, P < 0.0001). Protein-bound SH groups and uric acid were significantly lower in diabetic subjects, while MDA and vitamin E level were significantly higher. After correction for serum triglycerides (MDA) and cholesterol (vitamin E), MDA lost significance, while vitamin E did not. Vitamin C was not different in the two groups. CONCLUSIONS: These data show decreased TRAP levels in NIDDM patients, suggesting the existence of lower antioxidant defenses in diabetes. The decrease appears to be due to various antioxidants, some of them not yet clearly defined. TRAP may represent a more reliable estimation of serum antioxidant capacity than the measurement of each known antioxidants. The correlation found between TRAPm and TRAPc values suggests that TRAPc, easier to measure than TRAPm, might be adequately reliable for routine assessment of oxidative stress in diabetic patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Monge, N. Ledeme, H. Mazouz, J.-D. Lalau, M. Moubarak, C. Presne, A. Fournier, J.-C. Maziere, G. Choukroun, and P.-F. Westeel Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1979 - 1985. [Abstract] [Full Text] [PDF]

				A. Lapolla, F. Piarulli, G. Sartore, A. Ceriello, E. Ragazzi, R. Reitano, L. Baccarin, B. Laverda, and D. Fedele Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease Diabetes Care, March 1, 2007; 30(3): 670 - 676. [Abstract] [Full Text] [PDF]

				M. Liang and J. L. Pietrusz Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2 Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 77 - 83. [Abstract] [Full Text] [PDF]

				R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2368 - 2374. [Abstract] [Full Text] [PDF]

				A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman Oxidative Stress in the Pathogenesis of Diabetic Neuropathy Endocr. Rev., August 1, 2004; 25(4): 612 - 628. [Abstract] [Full Text] [PDF]

				M. Atalay, N. K. J. Oksala, D. E. Laaksonen, S. Khanna, C. Nakao, J. Lappalainen, S. Roy, O. Hanninen, and C. K. Sen Exercise training modulates heat shock protein response in diabetic rats J Appl Physiol, August 1, 2004; 97(2): 605 - 611. [Abstract] [Full Text] [PDF]

				M. Sacco, F. Pellegrini, M. C. Roncaglioni, F. Avanzini, G. Tognoni, and A. Nicolucci Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients: Results of the Primary Prevention Project (PPP) trial Diabetes Care, December 1, 2003; 26(12): 3264 - 3272. [Abstract] [Full Text] [PDF]

				J.-L. Chiasson, R. G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial JAMA, July 23, 2003; 290(4): 486 - 494. [Abstract] [Full Text] [PDF]

				P. Wentzel, A. Ejdesjo, and U. J. Eriksson Maternal Diabetes In Vivo and High Glucose In Vitro Diminish GAPDH Activity in Rat Embryos Diabetes, May 1, 2003; 52(5): 1222 - 1228. [Abstract] [Full Text] [PDF]

				B. S. O'Connell Select Vitamins and Minerals in the Management of Diabetes Diabetes Spectr, August 1, 2001; 14(3): 133 - 148. [Abstract] [Full Text] [PDF]

				D.W. Laight, M.J. Carrier, and E.E. Anggard Antioxidants, diabetes and endothelial dysfunction Cardiovasc Res, August 18, 2000; 47(3): 457 - 464. [Abstract] [Full Text] [PDF]

				A. Quinones-Galvan, A. M. Sironi, S. Baldi, F. Galetta, U. Garbin, A. Fratta-Pasini, L. Cominacini, and E. Ferrannini Evidence That Acute Insulin Administration Enhances LDL Cholesterol Susceptibility to Oxidation in Healthy Humans Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2928 - 2932. [Abstract] [Full Text] [PDF]

				S.L. Nuttall, F. Dunne, M.J. Kendall, and U. Martin Age-independent oxidative stress in elderly patients with non-insulin-dependent diabetes mellitus QJM, January 1, 1999; 92(1): 33 - 38. [Abstract] [Full Text] [PDF]